Biopsy tolerance study ends early – what we know
NCT ID NCT05022420
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to understand how well patients tolerate biopsies for autoimmune diseases and whether they feel properly informed. It planned to enroll 505 people but was terminated early. The results may help improve patient experience with these common procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH de Quimper
Quimper, 20007, France
-
CHRU de Brest
Brest, 29609, France
-
CHU d'ANGERS
Angers, France
-
CHU de Bordeaux
Bordeaux, 33000, France
-
CHU de LILLE
Lille, 59037, France
-
CHU de Marseille
Marseille, France
-
CHU de Tours
Tours, France
-
Hôpital de la Salpétrière
Paris, 75013, France